Production (Stage)
Bruker Corporation
BRKR
$35.50
-$0.84-2.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.45B | 3.37B | 3.24B | 3.12B | 3.00B |
| Total Other Revenue | -- | -- | 13.10M | 13.10M | 13.10M |
| Total Revenue | 3.45B | 3.37B | 3.24B | 3.12B | 3.00B |
| Cost of Revenue | 1.73B | 1.68B | 1.62B | 1.54B | 1.48B |
| Gross Profit | 1.72B | 1.68B | 1.62B | 1.58B | 1.52B |
| SG&A Expenses | 923.00M | 892.80M | 855.60M | 803.90M | 760.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 4.90M | 3.80M | 19.30M | 10.40M | 8.80M |
| Total Operating Expenses | 3.05B | 2.96B | 2.85B | 2.69B | 2.56B |
| Operating Income | 400.00M | 410.00M | 388.40M | 432.90M | 442.10M |
| Income Before Tax | 158.90M | 205.20M | 392.30M | 456.70M | 510.70M |
| Income Tax Expenses | 80.30M | 91.40M | 87.80M | 103.80M | 107.60M |
| Earnings from Continuing Operations | 78.60 | 113.80 | 304.50 | 352.90 | 403.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.00M | -700.00K | 400.00K | -800.00K | -1.50M |
| Net Income | 79.60M | 113.10M | 304.90M | 352.10M | 401.60M |
| EBIT | 400.00M | 410.00M | 388.40M | 432.90M | 442.10M |
| EBITDA | 599.50M | 593.80M | 556.60M | 576.70M | 566.60M |
| EPS Basic | 0.53 | 0.76 | 2.08 | 2.42 | 2.75 |
| Normalized Basic EPS | 1.55 | 1.64 | 1.57 | 1.78 | 1.82 |
| EPS Diluted | 0.52 | 0.76 | 2.08 | 2.41 | 2.75 |
| Normalized Diluted EPS | 1.55 | 1.64 | 1.57 | 1.77 | 1.81 |
| Average Basic Shares Outstanding | 602.10M | 595.70M | 589.60M | 584.70M | 584.10M |
| Average Diluted Shares Outstanding | 603.90M | 597.90M | 591.90M | 587.20M | 586.90M |
| Dividend Per Share | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
| Payout Ratio | 38.44% | 26.70% | 9.81% | 8.44% | 7.30% |